Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21)
- Géraldine Nollevaux1,
- Christelle Devillé1,
- Benaïssa El Moualij2,
- Willy Zorzi2,
- Patricia Deloyer1,
- Yves-Jacques Schneider3,
- Olivier Peulen†1 and
- Guy Dandrifosse†1Email author
© Nollevaux et al; licensee BioMed Central Ltd. 2006
Received: 03 April 2006
Accepted: 02 May 2006
Published: 02 May 2006
The absorptive and goblet cells are the main cellular types encountered in the intestine epithelium. The cell lineage Caco-2 is a model commonly used to reproduce the features of the bowel epithelium. However, there is a strong debate regarding the value of Caco-2 cell culture to mimick in vivo situation. Indeed, some authors report in Caco-2 a low paracellular permeability and an ease of access of highly diffusible small molecules to the microvilli, due to an almost complete lack of mucus. The HT29-5M21 intestinal cell lineage is a mucin-secreting cellular population. A co-culture system carried out in a serum-free medium and comprising both Caco-2 and HT29-5M21 cells was developed. The systematic use of a co-culture system requires the characterization of the monolayer under a given experimental procedure.
In this study, we investigated the activity and localization of the alkaline phosphatase and the expression of IAP and MUC5AC genes to determine a correlation between these markers and the cellular composition of a differentiated monolayer obtained from a mixture of Caco-2 and HT29-5M21 cells. We observed that the culture conditions used (serum-free medium) did not change the phenotype of each cell type, and produced a reproducible model. The alkaline phosphatase expression characterizing Caco-2 cells was influenced by the presence of HT29-5M21 cells.
The culture formed by 75% Caco-2 and 25% HT29-5M21 produce a monolayer containing the two main cell types of human intestinal epithelium and characterized by a reduced permeability to macromolecules.
Among human intestinal diseases, intestinal inflammatory disorders, such as food allergies and Crohn's disease, are characterized by an increase in intestinal permeability [1–4]. The in vitro study of these pathologies as well as of permeability modulators requires the use of a cell model representing as closely as possible the physiological conditions.
The small intestinal epithelium is the main barrier preventing the molecules from the lumen (e.g. food, toxins) to reach the blood compartment . This epithelium is composed of several cell types: enterocyte, goblet cell, paneth cell, endocrine cell and stem cell [6, 7]. The absorptive and goblet cells are the two main cellular types in the intestinal epithelium. The apical side of the enterocytes is characterized by a brush border which contains several enzymes and which increases the surface for nutrient absorption. The goblet cells secrete a mucus [8, 9], which covers the apical membrane of intestinal cells and limits molecule absorption [10, 11]. The cellular phenotypes in the epithelium are influenced by cell-cell and cell-matrix interactions and are defined by the expression of specific genes .
In vitro models are increasingly developed to study drug and nutrient transport across the intestinal epithelium [13–16]. The intestinal cell lineage Caco-2 is the most commonly used cell model [17, 18]. However, some authors report in Caco-2 a low paracellular permeability [14, 16, 19] and an ease of access of highly diffusible small molecules to the microvilli, due to an almost complete lack of mucus . Caco-2 cells were obtained from human colon adenocarcinoma . It differentiates spontaneously when it grows to confluence . The alkaline phosphatase (EC 220.127.116.11.), coded by the IAP gene, is an enzyme widely used as a marker of differentiation in the Caco-2 cell type [22, 23]. The parental HT29 cell line was obtained from human colorectal cancer . The HT29-5M21 cell line results from the isolation of HT29 cells adapted to methotrexate (MTX, 10-5 M) [25, 26]. The differentiation of goblet cells is characterized by the secretion of several mucins . The MUC5AC mucin gene, usually expressed in the stomach, accounts for the major expressed mucin gene in HT29-MTX [28, 29].
The aim of our study is the development of a serum-free co-culture of human intestinal epithelium cell lines. This reproducible co-culture will form an epithelial monolayer exhibiting the two main cellular types encountered in the human intestinal epithelium. The systematic use of co-culture systems requires the characterization of the monolayer under a given experimental procedure. In this study, we investigated the activity and localization of alkaline phosphatase and the expression of IAP and MUC5AC genes to determine a correlation between these markers and the cellular composition of a differentiated monolayer obtained from a mixture of Caco-2 and HT29-5M21 intestinal cells.
Enzyme activity and localization
Specificity of the primers
List of primers used in this study
Predicted PCR product size (bp)
IAP hu Fo
IAP hu Ba
bACT hu Fo
bACT hu Ba
Expression of IAP and MUC5AC genes
The expression level of IAP and MUC5AC genes was determined by real-time PCR in the Caco-2 and HT29-5M21 co-cultures. After 40 PCR cycles, the fluorescence, corresponding to SYBER Green® binding, was recorded and plotted against the cycle number (data not shown).
To understand the cellular events leading to a leaky gut in pathologies such as inflammatory bowel diseases, an in vitro approach using cell models is required. The intestinal cell lineage Caco-2 is the cell model most commonly used to reproduce the features of the human small intestine epithelium [17, 18]. Nevertheless, the Caco-2 cell model is different in some respects to the human epithelium. For example, it has a low paracellular permeability and allows access of highly diffusible small molecules to the microvilli too easily [14, 17, 19, 30, 31], owing to the lack of an adequate mucus layer. As an alternative, therefore, we analyzed the properties of a co-culture of Caco-2 cells and HT29-5M21 cells differentiating spontaneously into mucus-secreting cells. This co-culture system exhibits the two main important cellular types encountered in the human intestinal epithelium. In order to make this procedure reliable and reproducible, we replaced the usual serum-containing culture medium with a serum-free medium supplemented with hormones and amino acids. Although the proportions of both cellular types are determined at culture seeding, they can rapidly modify during culture owing to the ability of each cell line to adhere to and to proliferate on the culture substrate. More, the heterogeneity of Caco-2 cells between 0 and 30 days of confluence  can deeply influence the co-culture composition.
A brief characterization of the Caco-2/HT29-5M21 co-culture, initially seeded with a 3:1 ratio, was performed. Results showed a monolayer containing few cells with condensed DNA (ethidium bromide accumulation). The ethidium bromide accumulation may reflect an early proliferative/apoptotic activity and modified nucleic acid expression. Indeed, an increase in DNA content is a feature of actively-proliferating cells that would therefore exhibit higher fluorescence peaks when labeled by ethidium bromide . Moreover, previous studies reported the appearance of an increase in DNA staining by ethidium bromide during the early phases of apoptosis, known as the hyperdiploid peak, . On the other hand, intracellular ethidium bromide fluorescence could also be enhanced by an increase in DNA base pair accessibility associated with the differentiation state . Then, a recent study indeed suggests that cell proliferation and apoptosis can co-exist . In our case we can not speculate between these possibilities. Whatever the solution may be, our results show that our co-culture has a high proportion of living cells.
For this study, we used alkaline phosphatase as an indicator of the cell proportion in co-culture models. The alkaline phosphatase is a membrane-bound enzyme localized in the brush border of enterocytes in the human intestinal epithelium and was used previously by Matsumoto et al.  to monitor the differentiation of enterocyte-like cells. In order to analyze the correlation between the proportion of the enterocyte-like cells and the alkaline phosphatase in the Caco-2/HT29-5M21 co-cultures, we estimated the enzyme SA. This enzyme activity is increased with the Caco-2 proportion. However, the alkaline phosphatase SA in co-cultures seems to be higher than in cell mixtures with the same proportions (1:3, 2:2 and 3:1). This result suggests a positive interaction between Caco-2 and HT29-5M21 cells. This interaction could lead to an increase of the gene expression, an increase of the translation rate or a decrease of enzyme degradation. This last possibility was already proposed by Matsumoto et al.  during cell differentiation.
The alkaline phosphatase activity was detected in co-cultures by the cytochemistry method. Our results show that the alkaline phosphatase was restricted to the enterocyte-like cell and could then be used as a potential marker for the monitoring of these cells under several co-culture conditions. The discrepancy between the alkaline phosphatase-positive area and the Caco-2 seeding proportion in culture could be explained by the heterogeneity of the cell lineage . Indeed, this cell line differentiates spontaneously in enterocyte-like cells, but also in other cell types which do not express alkaline phosphatase. Our results underline this heterogeneity, as we observed, by cytochemistry at cellular level, several red-scales (meaning alkaline phosphatase activity) in the same culture. This differentiation seems to be influenced by the Caco-2/HT29-5M21 co-culture and thus by a cell-cell interaction.
In order to collect more data on the proportionate composition of the monolayer, we investigated the expression level of the alkaline phosphatase coding gene and of the MUC5AC gene. Though the two cell lineages were both of an adenocarcinoma origin [16, 21, 24], we showed that the IAP and MUC5AC gene expressions are restricted, respectively, to Caco-2 cells and HT29-5M21 cells. We showed by real-time PCR that the expression level of the IAP and MUC5AC genes in the monolayer is independent of the cell proportion and thus of the Caco-2 or HT29-5M21 abundancy. However, the specific activity of the alkaline phosphatase was dependant on the Caco-2 proportion. Consequently, there is a complex control of the gene expression, enzyme translation and degradation regarding the cell-cell interaction.
Monolayer permeability is influenced by the presence of HT29-5M21 cells in the system. This influence is in accordance with an increase of the permeability. Indeed, we showed a decrease of the TEER and an increase of the Lucifer yellow and 20 kDa dextran permeability with the increase of HT29-5M21 proportion in the monolayer at seeding. The cell ratio is established at seeding and is probably not indicative of the situation when permeability is measured. However, HT29-5M21 cells seem to remain in sufficient proportion in the culture to increase cell permeability. The range of molecular masses (Lucifer yellow 452 Da & dextran 20 kDa) used in this study to explore monolayer permeability allow to characterize para-cellular permeability [37, 38]. Lucifer yellow is not absorbed by epithelial cell but is able to pass through cell junctions as mannitol does. Dextrans are largely used as macromolecule permeability tracer.
The phosphatase alkaline, a well-established marker for enterocyte-like cells, could be proposed, in combination with MUC5AC, as a new marker of great interest for monitoring the cellular composition of the co-culture. We are currently developing an immuno-labelling system to quantify the level of this protein.
On the basis of the enterocyte/goblet cell ratio observed in vivo [39, 40], the cell proportion 3:1 allows us to decrease the permeability to macromolecules who becomes closer to the situation observed in a human intestinal epithelium.
Permeability studies, using this co-culture, indicate that Caco-2/HT29-5M21 co-culture is more permissive than Caco-2 cell culture regarding to para-cellular permeability. This characteristic is probably in accordance with the in vivo permeability. We can expect to use the model to study some human diseases involving permeability alterations as coeliac disease.
All chemicals were purchased from Sigma-Aldrich (Poole, Dorset, UK) and from VWR (Brussels, Belgium). Cell culture media were obtained from Gibco BRL (Merelbeke, Belgium) and from Sigma-Aldrich. The molecular biology reagents were obtained from Promega (Madison, USA). Lucifer yellow and 20 kDa-dextran were obtained from Sigma-Aldrich.
Cell lines and culture conditions
The HT29-5M21 cell line, derived from the HT29-MTX 10-5M cell line , was obtained at passage 9 from Dr. T. Lesuffleur (INSERM U505, Villejuif, France). Caco-2 cells were obtained at passage 22 from Cambrex Bio Science (Verviers, Belgium). These cells were progressively adapted (until passage 30 for HT29-5M21 and passage 40 for Caco-2) to a serum-free medium: the basal defined medium (BDM)  supplemented with a mixture of non-essential amino acids and growth factors . Initially, Caco-2 and HT29-5M21 cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) containing glucose (4.15 mg/l) buffered with HEPES (25 mM) containing fetal calf serum (10%) and antibiotics (1%: penicillin [1 U/ml], streptomycin [1 μg/ml] and amphotericin as fungizone® [2.5 ng/ml]). Then, these cells were progressively sub-cultured in BDM containing glucose (4.15 mg/l) supplemented with non-essential amino acids and growth factors . Cells were used at passages 30 (HT29-5M21) and 40 (Caco-2) to avoid dedifferentiation . The cells were seeded at 4 × 104 cells/cm2 in plastic flasks (Greiner labortechnik SA, Wemmel, Belgium) and cultured at 37°C in a CO2-air (5:95) atmosphere (Heraeus EK incubator). The culture medium was changed every day.
Five types of culture cells were produced: Caco-2 cells alone, HT29-5M21 cells alone and co-cultures of these cells in various seeding ratios (1:3, 2:2 and 3:1). These cultures (4 × 104 cells/cm2 per flask) were maintained in BDM supplemented with non-essential amino acids, a mixture of growth factors  and antibiotics (see above). The medium was changed every two days. Co-cultures were confluent 7 days after the seeding. The Caco-2 and HT29-5M21 cells were maintained in culture during 21 days of differentiation after confluence. Under these conditions, the maximum expression of intestinal differentiation-specific markers was achieved. For the enterocytes, the differentiation marker was the alkaline phosphatase activity associated with the microvilli [17, 30, 31]. With regard to the goblet cells, the differentiation marker was the mucin synthesis . Cells were used for mRNA extraction, enzyme assays and localization. Cells in co-culture were briefly characterized by phase contrast microscopy, light microscopy (semi-thin cross sections stained with toluidine blue), electronic microscopy and vital dye (ethidium bromide/acridine orange) exclusion .
Permeability analyses were performed on cells cultured on 0.4 μm polyethylene terephtalate membrane coated with collagen as described above. Transepithelial electrical resistance measurement was measured in Hank's buffer [46, 47]. Lucifer yellow and fluorescent dextran were measured in the baso-lateral pole compartment with a fluorimeter (excitation 430 nm – emission 540 nm).
Enzyme activity assays were performed on cell homogenates. Just before use, the monolayer was washed with PBS buffer (pH 7.2) and 1 ml of water was added. Cells were collected by scraping and were disrupted by ultrasonication (3 times for 20 sec each; ultrasonicer MSE PE818). Enzyme activity was assayed on co-culture homogenates and on Caco-2 and HT29-5M21 homogenate mixtures in 1:3, 2:2 and 3:1 ratios. Alkaline phosphatase activity was assayed according to the method described by Garen and Levinthal , with p-nitrophenolphosphate as substrate. Results were expressed as milliunit mg-1 of protein (specific activity = SA). One unit was defined as the activity equal to one μmol of substrate hydrolyzed per min at 37°C. Proteins were assayed by the method described by Bradford . Phosphatase alkaline activity was localized on cell culture by cytochemistry using the fast red substrate (naphtol combined to fast red; Roche Diagnostics GmbH, Penzberg, Germany). Labelled cell-culture pictures were analyzed using ImageJ 1.33u software (Wayne Rasband, NIH, USA). Images were converted in 256 greyscale files, then a threshold was defined in order to include the red channel in the selection. The area of the selection was measured as a percentage of the picture surface.
All the PCR primers used in this study were obtained from Eurogentec (Seraing, Belgium). Three pairs of primers were chosen: IAP hu Fo/Ba was a specific of an alkaline phosphatase gene; MUC5AC Fo/Ba was a specific of the MUC5AC mucin gene ; and bACT hu Fo/Ba was a specific of the cytosolic beta actin coding-gene. The primer3 program  was used to design the IAP hu Fo/Ba and bACT hu Fo/Ba primers. The sequences of the primers used in this study are presented in Table I.
Total mRNA was isolated using a kit manufactured by Promega (RNagents® total RNA isolation system) from confluent monolayer cells. RNA integrity was checked by electrophoresis in agarose gel (1%) containing ethidium bromide (0.5 μg/ml). RNA concentration was estimated by spectrophotometry at 260 nm.
cDNA was synthesized using 5 μg of DNase-treated mRNA in a reaction mixture containing RT buffer (1x), dNTP (0.6 mM), RNase inhibitor (1 U/μl), OligodT primers (0.2 μM) and RT Mo-MuLV (0.008 U/μl). The mix was incubated for 1 h at 42°C.
PCR and real-time PCR
The PCR was performed on the cDNA in a final volume of 50 μl. A sample (2 μl) of this cDNA (0.04 μg) was added to the PCR mixture containing Mg2+ free buffer (1x), MgCl2 (2.5 mM for IAP hu Fo/Ba, 3 mM for MUC5AC Fo/Ba and 1.5 mM for bACT hu Fo/Ba), dNTP (200 μM), primers (1 μM each) and Taq polymerase (0.1 U). The PCR was carried out with a thermal cycler (Thermolyne, Amplitron® II).
The real-time PCR has been described elsewhere . In our conditions, we used the SYBER®Green, which is a double-strand DNA dye that gives rise to a fluorescence when it is intercalated between DNA bases. Real-time PCR was carried out in a final volume of 50 μl containing 25 μl of SYBER®Green PCR Master Mix (Applied Biosystems), 2 μl of cDNA (0.04 μg) and 1μM of each primer.
In both procedures, the reaction was performed in duplicate for each cDNA. The PCR conditions were as follows: initial denaturation step at 95°C for 3 min, followed by 40 cycles at 95°C for 1 min, annealing temperature for 1 min (60°C for IAP hu Fo/Ba, 62°C for MUC5AC Fo/Ba and 60°C for bACT hu Fo/Ba) and 72°C for 1 min. A final elongation step was performed for 5 min at 72°C.
The PCR products (10 μl) were separated by electrophoresis in agarose gels (1%) containing ethidium bromide (0.5 μg/ml). The nucleolytic DNA polymerase overlapped the hybridization probe, and the resulting relative increase in the reporter fluorescent dye emission was monitored in real time using a sequence detector (GeneAmp 5700 System, Applied Biosystems). The fluorescence intensity was a function of the cycle number and was determined using the sequence detector software (Applied Biosystems), giving the Ct at which PCR amplification reached the exponential phase. The Ct was plotted against the culture types. The value of the Ct was inversely linearly correlated with the logarithmic value of cDNA quantity.
Results are reported as mean ± standard deviation (SD). With regard to heteroscedasticity, statistical analysis was performed using Newman-Student-Keuls or Kruskal-Wallis ANOVA. A p-value below 0.05 was considered statistically significant.
This work was supported by the Foundation for Industry and Agriculture Research (FRIA grant N° F3/5/5-FC-20.113), and received the financial support of the "RegionWallonne" (grant N° 991/4206). The authors thank Mrs D Zorzi and M Klimek for their assistance in real-time PCR and in alkaline phosphatase assays.
- Bjarnason I, Macpherson A, Hollander D: Intestinal permeability: an overview. Gastroenterology. 1995, 108: 1566-1581. 10.1016/0016-5085(95)90708-4.View ArticlePubMedGoogle Scholar
- Lennernas H: Human intestinal permeability. J Pharm Sci. 1998, 87: 403-410. 10.1021/js970332a.View ArticlePubMedGoogle Scholar
- DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC: Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002, 34: 385-396. 10.1097/00004836-200204000-00003.View ArticlePubMedGoogle Scholar
- Farhadi A, Banan A, Fields J, Keshavarzian A: Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol. 2003, 18: 479-497. 10.1046/j.1440-1746.2003.03032.x.View ArticlePubMedGoogle Scholar
- Baumgart DC, Dignass AU: Intestinal barrier function. Curr Opin Clin Nutr Metab Care. 2002, 5: 685-694. 10.1097/00075197-200211000-00012.View ArticlePubMedGoogle Scholar
- Cheng H, Leblond CP: Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat. 1974, 141: 537-561. 10.1002/aja.1001410407.View ArticlePubMedGoogle Scholar
- Potten CS: Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci. 1998, 353: 821-830. 10.1098/rstb.1998.0246.PubMed CentralView ArticlePubMedGoogle Scholar
- Moe H: Mucus-producing goblet cells of the small intestine. Nature. 1953, 172: 309-10.1038/172309a0.View ArticlePubMedGoogle Scholar
- Bierring F: Electron microscopic observations on the mucus production in human and rat intestinal goblet cells. Acta Pathol Microbiol Scand. 1962, 54: 241-252.View ArticlePubMedGoogle Scholar
- Allen JD, Martin GP, Marriott C, Hassan I, Williamson I: Drug transport across a novel mucin secreting cell model: Comparison with the CaCo-2 cell system [abstract]. J Pharm Pharmacol. 1991, 43: 63P-View ArticleGoogle Scholar
- Meaney C, O'Driscoll C: Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models. Eur J Pharm Sci. 1999, 8: 167-175. 10.1016/S0928-0987(99)00007-X.View ArticlePubMedGoogle Scholar
- Simon-Assmann P, Kedinger M, De Arcangelis A, Rousseau V, Simo P: Extracellular matrix components in intestinal development. Experientia. 1995, 51: 883-900. 10.1007/BF01921739.View ArticlePubMedGoogle Scholar
- Wikman-Larhed A, Artursson P: Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption. Eur J Pharm Sci. 1995, 3: 171-193. 10.1016/0928-0987(95)00007-Z.View ArticleGoogle Scholar
- Walter E, Janich S, Roessler BJ, Hilfinger JM, Amidon GL: HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci. 1996, 85: 1070-1076. 10.1021/js960110x.View ArticlePubMedGoogle Scholar
- Hilgendorf C, Spahn-Langguth H, Regardh CG, Lipka E, Amidon GL, Langguth P: Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci. 2000, 89: 63-75. 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6.View ArticlePubMedGoogle Scholar
- Artursson P, Palm K, Luthman K: Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2001, 46: 27-43. 10.1016/S0169-409X(00)00128-9.View ArticlePubMedGoogle Scholar
- Meunier V, Bourrie M, Berger Y, Fabre G: The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol. 1995, 11: 187-194. 10.1007/BF00756522.View ArticlePubMedGoogle Scholar
- Ingels FM, Augustijns PF: Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2. J Pharm Sci. 2003, 92: 1545-1558. 10.1002/jps.10408.View ArticlePubMedGoogle Scholar
- Menon RM, Barr WH: Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambers. Biopharm Drug Dispos. 2003, 24: 299-308. 10.1002/bdd.366.View ArticlePubMedGoogle Scholar
- Pinto M, Robine-Léon S, Appay MD, Kedinger M, Triadou N, Dussaulx E, Lacroix B, Simon-Assmann P, Haffen K, Fogh J, Zweibaum A: Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell. 1983, 47: 323-330.Google Scholar
- Rousset M: The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie. 1986, 68: 1035-1040.View ArticlePubMedGoogle Scholar
- Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A: Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res. 1988, 48: 1936-1942.PubMedGoogle Scholar
- Matsumoto H, Erickson RH, Gum JR, Yoshioka M, Gum E, Kim YS: Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2. Gastroenterology. 1990, 98: 1199-1207.PubMedGoogle Scholar
- Fogh J, Trempe G: New human tumor cell lines. Human Tumor Cells in vitro. Edited by: Fogh J. 1975, New-York: Plenum Publishing Corp, 115-141.View ArticleGoogle Scholar
- Lesuffleur T, Barbat A, Luccioni C, Beaumatin J, Clair M, Kornowski A, Dussaulx E, Dutrillaux B, Zweibaum A: Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells. J Cell Biol. 1991, 115: 1409-1418. 10.1083/jcb.115.5.1409.View ArticlePubMedGoogle Scholar
- Wils P, Warnery A, Phung-Ba V, Scherman D: Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell Biol Toxicol. 1994, 10: 393-397. 10.1007/BF00755788.View ArticlePubMedGoogle Scholar
- Lesuffleur T, Porchet N, Aubert JP, Swallow D, Gum JR, Kim YS, Real FX, Zweibaum A: Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J Cell Sci. 1993, 106: 771-783.PubMedGoogle Scholar
- Fergie N, Guo L, Sithole J, Pearson JP, Birchall JP: Influence of prednisolone on the secretion of mucin from the HT29-MTX cell line. Clin Otolaryngol Allied Sci. 2003, 28: 39-42. 10.1046/j.1365-2273.2003.00656.x.View ArticlePubMedGoogle Scholar
- Gouyer V, Wiede A, Buisine MP, Dekeyser S, Moreau O, Lesuffleur T, Hoffmann W, Huet G: Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secreting phenotype. Biochim Biophys Acta. 2001, 1539: 71-84. 10.1016/S0167-4889(01)00092-1.View ArticlePubMedGoogle Scholar
- Quaroni A, Beaulieu JF: Cell dynamics and differentiation of conditionally immortalized human intestinal epithelial cells. Gastroenterology. 1997, 113: 1198-1213. 10.1053/gast.1997.v113.pm9322515.View ArticlePubMedGoogle Scholar
- Artursson P, Borchardt RT: Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm Res. 1997, 14: 1655-1658. 10.1023/A:1012155124489.View ArticlePubMedGoogle Scholar
- Vachon PH, Beaulieu JF: Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology. 1992, 103: 414-423.PubMedGoogle Scholar
- Bonaly J, Mestre JC: Flow fluorometric study of DNA content in nonproliferative Euglena gracilis cells and during proliferation. Cytometry. 1981, 2: 35-38. 10.1002/cyto.990020108.View ArticlePubMedGoogle Scholar
- Ferlini C, Di CS, Rainaldi G, Malorni W, Samoggia P, Biselli R, Fattorossi A: Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry. 1996, 24: 106-115. 10.1002/(SICI)1097-0320(19960601)24:2<106::AID-CYTO2>3.0.CO;2-H.View ArticlePubMedGoogle Scholar
- Darzynkiewicz Z, Traganos F, Kapuscinski J, Staiano-Coico L, Melamed MR: Accessibility of DNA in situ to various fluorochromes: relationship to chromatin changes during erythroid differentiation of Friend leukemia cells. Cytometry. 1984, 5: 355-363. 10.1002/cyto.990050411.View ArticlePubMedGoogle Scholar
- Nagy Z, Esiri MM: Neuronal cyclin expression in the hippocampus in temporal lobe epilepsy. Exp Neurol. 1998, 150: 240-247. 10.1006/exnr.1997.6753.View ArticlePubMedGoogle Scholar
- Konsoula R, Barile FA: Correlation of in vitro cytotoxicity with paracellular permeability in Caco-2 cells. Toxicol In Vitro. 2005, 19: 675-684. 10.1016/j.tiv.2005.03.006.View ArticlePubMedGoogle Scholar
- Satsu H, Yokoyama T, Ogawa N, Fujiwara-Hatano Y, Shimizu M: Effect of neuronal PC12 cells on the functional properties of intestinal epithelial Caco-2 cells. Biosci Biotechnol Biochem. 2003, 67: 1312-1318. 10.1271/bbb.67.1312.View ArticlePubMedGoogle Scholar
- Cheng H, Leblond CP: Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell. Am J Anat. 1974, 141: 461-479. 10.1002/aja.1001410403.View ArticlePubMedGoogle Scholar
- Rubio CA, Lindholm J, Rodensjo M: Mapping intestinal metaplasia by histochemistry and morphometry. Pathol Res Pract. 1989, 184: 525-528.View ArticlePubMedGoogle Scholar
- Schneider YJ: Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined, serum- and protein-free culture medium. J Immunol Methods. 1989, 116: 65-77. 10.1016/0022-1759(89)90314-1.View ArticlePubMedGoogle Scholar
- Halleux C, Schneider YJ: Iron absorption by intestinal epithelial cells: 1. CaCo2 cells cultivated in serum-free medium, on polyethyleneterephthalate microporous membranes, as an in vitro model. In Vitro Cell Dev Biol. 1991, 27A: 293-302.View ArticlePubMedGoogle Scholar
- Yu H, Cook TJ, Sinko PJ: Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm Res. 1997, 14: 757-762. 10.1023/A:1012150405949.View ArticlePubMedGoogle Scholar
- Hennebicq-Reig S, Lesuffleur T, Capon C, De BC, Kim I, Moreau O, Richet C, Hemon B, Recchi MA, Maes E, Aubert JP, Real FX, Zweibaum A, Delannoy P, Degand P, Huet G: Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion. Biochem J. 1998, 334: 283-295.PubMed CentralView ArticlePubMedGoogle Scholar
- Foglieni C, Meoni C, Davalli AM: Fluorescent dyes for cell viability: an application on prefixed conditions. Histochem Cell Biol. 2001, 115: 223-229.PubMedGoogle Scholar
- Lu S, Gough AW, Bobrowski WF, Stewart BH: Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes. J Pharm Sci. 1996, 85: 270-273. 10.1021/js950269u.View ArticlePubMedGoogle Scholar
- Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H: Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci. 2000, 10: 195-204. 10.1016/S0928-0987(00)00076-2.View ArticlePubMedGoogle Scholar
- Garen A, Levinthal C: A fine-structure genetic and chemical study of the enzyme alkaline phosphatase of E. coli. I. Purification and characterization of alkaline phosphatase. Biochim Biophys Acta. 1960, 38: 470-483. 10.1016/0006-3002(60)91282-8.View ArticlePubMedGoogle Scholar
- Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.View ArticlePubMedGoogle Scholar
- Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000, 132: 365-386.PubMedGoogle Scholar
- Latil A, Vidaud D, Valeri A, Fournier G, Vidaud M, Lidereau R, Cussenot O, Biache I: htert expression correlates with MYC over-expression in human prostate cancer. Int J Cancer. 2000, 89: 172-176. 10.1002/(SICI)1097-0215(20000320)89:2<172::AID-IJC12>3.0.CO;2-8.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.